SEC 13F Intelligence

Schroder Investment Management Group / ELV

Schroder Investment Management Group’s Elevance Health Inc Formerly Position

Does Schroder Investment Management Group own Elevance Health Inc Formerly (ELV)? Yes101.1K shares worth $30M (+0.02% of its 13F portfolio) as of Q1 2026, down from 110.2K shares the prior filed quarter.

Position Value
$30M
Q1 2026
Shares
101.1K
% of Portfolio
+0.02%
Quarters Held
30
currently held

Position History ELV

Reported value by quarter
Q4 ’18: $10MQ4 ’18Q1 ’19: $12MQ2 ’19: $33MQ3 ’19: $147MQ4 ’19: $203MQ4 ’19Q1 ’20: $138MQ2 ’20: $179MQ3 ’20: $246MQ4 ’20: $468MQ4 ’20Q1 ’21: $316MQ2 ’21: $362MQ3 ’21: $338MQ4 ’21: $541MQ4 ’21Q1 ’22: $605MQ2 ’22: $606MQ3 ’22: $542MQ4 ’22: $600MQ4 ’22Q1 ’23: $518MQ2 ’23: $500MQ3 ’23: $579MQ4 ’23: $704MQ4 ’23Q1 ’24: $885MQ2 ’24: $1.1BQ3 ’24: $882MQ4 ’24: $431MQ4 ’24Q1 ’25: $469MQ2 ’25: $541MQ3 ’25: $48MQ4 ’25: $39MQ4 ’25Q1 ’26: $30Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026101.1K$30M+0.02%
Q4 2025110.2K$39M+0.03%
Q3 2025147.9K$48M+0.04%
Q2 20251.39M$541M+0.46%
Q1 20251.09M$469M+0.47%
Q4 20241.17M$431M+0.41%
Q3 20241.68M$882M+0.90%
Q2 20242.06M$1.1B+1.23%
Q1 20241.71M$885M+1.04%
Q4 20231.49M$704M+0.91%
Q3 20231.33M$579M+0.86%
Q2 20231.13M$500M+0.72%
Q1 20231.13M$518M+0.77%
Q4 20221.17M$600M+0.95%
Q3 20221.19M$542M+0.90%
Q2 20221.26M$606M+0.92%
Q1 20221.20M$605M+0.80%
Q4 20211.17M$541M+0.71%
Q3 2021907.3K$338M+0.52%
Q2 2021949.4K$362M+0.45%
Q1 2021880.4K$316M+0.41%
Q4 20201.46M$468M+0.33%
Q3 2020893.6K$246M+0.39%
Q2 2020679.3K$179M+0.32%
Q1 2020612.2K$138M+0.30%
Q4 2019673.6K$203M+0.33%
Q3 2019617.3K$147M+0.26%
Q2 2019117.2K$33M+0.06%
Q1 201942.4K$12M+0.02%
Q4 201837.4K$10M+0.02%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Schroder Investment Management Group’s full portfolio or all institutional holders of ELV.